» Articles » PMID: 16325151

Generalized and Specific Neurocognitive Deficits in Prodromal Schizophrenia

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2005 Dec 6
PMID 16325151
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neurocognitive deficits are considered to be central to the pathophysiology of schizophrenia, and the neurodevelopmental model suggests that such deficits precede full-blown psychosis. The present study examined performance on a broad neuropsychological battery of young subjects considered to be at clinical high risk for schizophrenia, who were subsequently followed to determine clinical outcome.

Methods: Subjects were 38 clinical high-risk patients (58% male patients; mean age = 16.5) and 39 sex- and age-matched healthy control subjects. At baseline, all high-risk patients had attenuated (subpsychotic) schizophrenialike positive symptoms. Clinical follow-up data of at least 6 months duration was available on 33 patients, of whom 12 developed nonaffective psychotic disorders.

Results: At baseline, clinical high-risk patients had significantly impaired global cognitive performance relative to control subjects and to estimates of their own prior intellectual functioning. Measures of verbal memory and executive functioning/working memory showed significantly greater impairments; visuospatial functioning was relatively spared. Prodromal patients who later developed psychosis had significantly lower verbal memory scores at baseline compared with patients who remained nonpsychotic.

Conclusions: Verbal memory deficits may be an important risk marker for the development of schizophrenia-spectrum psychotic disorders, possibly indicating the presence of a prefrontal-hippocampal neurodevelopmental abnormality. Generalized neurocognitive impairment may be a nonspecific vulnerability marker.

Citing Articles

Robust Brain Correlates of Cognitive Performance in Psychosis and Its Prodrome.

Ward H, Beermann A, Xie J, Yildiz G, Felix K, Addington J Biol Psychiatry. 2024; 97(2):139-147.

PMID: 39032726 PMC: 11634655. DOI: 10.1016/j.biopsych.2024.07.012.


Effect of cognitive behavioral group therapy on rehabilitation of community patients with schizophrenia: A short-term randomized control trial.

Chen X, Deng X, Sun F, Huang Q World J Psychiatry. 2023; 13(8):583-592.

PMID: 37701538 PMC: 10494774. DOI: 10.5498/wjp.v13.i8.583.


Association between Empathy and Clinical Symptoms among Overweight and Non-Overweight Chinese Chronic Schizophrenia Patients.

Li Y, Luo R, Wang D, Zhang X Brain Sci. 2023; 13(7).

PMID: 37509007 PMC: 10377734. DOI: 10.3390/brainsci13071075.


Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.

Pedruzo B, Aymerich C, Pacho M, Herrero J, Laborda M, Bordenave M Eur Child Adolesc Psychiatry. 2023; 33(10):3377-3387.

PMID: 37199754 PMC: 11564316. DOI: 10.1007/s00787-023-02221-9.


Cognitive predictors of transition and remission of psychosis risk syndrome in a child and adolescent sample: longitudinal findings from the CAPRIS study.

Tor J, Baeza I, Sintes-Estevez A, de la Serna E, Puig O, Munoz-Samons D Eur Child Adolesc Psychiatry. 2023; 33(1):89-104.

PMID: 36598585 DOI: 10.1007/s00787-022-02137-w.